Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Almudena Sánchez-Gómez"'
Autor:
Viviana Torres, Kirsys Del Giudice, Pedro Roldán, Jordi Rumià, Esteban Muñoz, Ana Cámara, Yaroslau Compta, Almudena Sánchez-Gómez, Francesc Valldeoriola
Publikováno v:
npj Parkinson's Disease, Vol 10, Iss 1, Pp 1-9 (2024)
Abstract Deep brain stimulation (DBS) is an effective treatment for patients with Parkinson’s disease (PD). However, some patients may not respond optimally to clinical programming adjustments. Advances in DBS technology have led to more complex an
Externí odkaz:
https://doaj.org/article/a2468d9b7c5d4c43b27618e103aefb8e
Autor:
Teresa Mena-Moreno, Lucero Munguía, Rosario Granero, Ignacio Lucas, Almudena Sánchez-Gómez, Ana Cámara, Yaroslau Compta, Francesc Valldeoriola, Fernando Fernandez-Aranda, Anne Sauvaget, José M Menchón, Susana Jiménez-Murcia
Publikováno v:
JMIR Serious Games, Vol 10, Iss 3, p e33858 (2022)
BackgroundImpulse control disorders (ICDs) are commonly developed among patients who take dopamine agonist drugs as a treatment for Parkinson disease (PD). Gambling disorder and hypersexuality are more frequent in male patients with PD, with a preval
Externí odkaz:
https://doaj.org/article/f3e3bbde48df46409ab4a570f0efa4cd
Autor:
Almudena Sánchez-Gómez, Paola Camargo, Ana Cámara, Pedro Roldán, Jordi Rumià, Yaroslau Compta, Álvaro Carbayo, Maria José Martí, Esteban Muñoz, Francesc Valldeoriola
Publikováno v:
World Neurosurgery. 166:e163-e176
The objective of this study was to evaluate the accuracy of the SureTune3 postoperative imaging software in determining the location of a deep brain stimulation (DBS) electrode based on clinical outcomes and the adverse effects (AEs) observed.Twenty-
Publikováno v:
Parkinsonism & Related Disorders. 89:22-27
Background Association of type 2 diabetes mellitus (T2D) with subsequent Parkinson's disease (PD) has supported the link between glucose metabolism and PD. We assessed the risk of PD not only in T2D but also in prediabetes. Methods We conducted a ret
Autor:
Mònica Serrano Clerencia, Almudena Sánchez-Gómez, Anna Grau Giner, Laura Cardete Morales, Sergi Amaro Delgado
Publikováno v:
Revista Científica de la Sociedad de Enfermería Neurológica (English ed.).
Autor:
Mònica Serrano Clerencia, Almudena Sánchez-Gómez, Anna Grau Giner, Laura Cardete Morales, Sergi Amaro Delgado
Publikováno v:
Revista Científica de la Sociedad Española de Enfermería Neurológica.
Autor:
Esteban Muñoz, Oriol Grau, Nuria Caballol, Alexandra Pérez-Soriano, Celia Painous, Ellen Gelpi, Mar Guasp, Francesc Valldeoriola, Alicia Garrido, Ana Cámara, Guenter H. Höglinger, Gesine Respondek, Almudena Sánchez-Gómez, María José Martí, Yaroslau Compta, Laura Molina-Porcel
Publikováno v:
Parkinsonism & related disorders 84, 77-81 (2021). doi:10.1016/j.parkreldis.2021.01.015
Introduction The MDS-PSP criteria expand the phenotypic spectrum of PSP by adding to Richardson's syndrome (PSP-RS) other presentations such as PSP-parkinsonism (PSP–P), PSP-pure-gait-freezing (PSP-PGF), PSP-speech-language (PSP-SL), PSP-frontal (P
Autor:
Francesc Valldeoriola-Serra, Nadia Gandarilla-Martínez, Álvaro Carbayo-Viejo, Almudena Sánchez-Gómez
Publikováno v:
Parkinsonism & Related Disorders. 80:181-183
Autor:
María José Martí, Rubén Fernández-Santiago, Mario Ezquerra, Yaroslau Compta, Almudena Sánchez-Gómez, Francesc Valldeoriola, Eduardo Tolosa, Esteban Muñoz, Anna Esteve-Codina, Manel Fernández
Publikováno v:
NPJ Parkinson's Disease
npj Parkinson's Disease, Vol 7, Iss 1, Pp 1-7 (2021)
npj Parkinson's Disease, Vol 7, Iss 1, Pp 1-7 (2021)
Type-2 diabetes (T2D) and glucose metabolic imbalances have been linked to neurodegenerative diseases, including Parkinson's disease (PD). To detect potential effects of different glucose levels on gene expression, by RNA-seq we analyzed the transcri
Autor:
Francesc Valldeoriola, Pilar Santacruz, Lluís Planellas, Esteban Muñoz, Tatiana Aldaz, Almudena Sánchez-Gómez, Pasquale Nigro, Yaroslau Compta, Celia Painous, Ana Cámara, María José Martí
Publikováno v:
Journal of Neurology. 266:1340-1350
The presence of non-motor symptoms in Huntington’s disease (HD) has not been systematically assessed so far. Our objective was to know their prevalence and to compare it with a cohort of patients with Parkinson’s disease (PD). Participants were c